Trazec
·
- Prescription status not stated
- Digestion, stomach, diabetes and nutrition
- Active substance
- Nateglinide
- Made by
- Novartis Europharm Ltd.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Nateglinide is indicated for combination therapy with metformin in type 2 diabetic patients inadequately controlled despite a maximally tolerated dose of metformin alone.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
Details
| Made by | Novartis Europharm Ltd. |
|---|---|
| Active substance | Nateglinide |
| Used in | Digestion, stomach, diabetes and nutrition |
| Classification | A10BX03 · Digestion, stomach, diabetes and nutrition |
| Authorised on | 2001-04-03 |
| Last updated by the regulator | 2009-08-24 |
| EMA product number | EMEA/H/C/000383 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.